Abstract
Inclusive participation is critical for community-based water, sanitation and hygiene (WASH) interventions, especially in complex environments such as urban informal settlements. We conducted a mixed-methods, theory-driven process evaluation to evaluate participation, barriers to participation, and participant satisfaction within the Revitalising Informal Settlements and their Environments (RISE) trial in Makassar, Indonesia and Suva, Fiji (ACTRN12618000633280; https://www.anzctr.org.au/).
RISE conducted participatory design activities, including community-level design workshops and household visits, to co-design WASH infrastructure. Household surveys, conducted with women and men after RISE participatory design in Makassar (N=320) and Suva (N=503), captured self-reported participation in RISE activities and satisfaction with influence over RISE decision-making. We used multivariable regression models to assess socio-demographic predictors of participation and satisfaction. Qualitative data were also collected after participatory design and analyzed thematically.
Most respondents from Makassar (89%) and Suva (75%) participated in at least one RISE co-design activity. Statistically significant predictors of participation included gender, age, and marital status in Makassar and disability status and education in Suva. Most participants in Makassar (66%) and Suva (70%) were satisfied with their level of influence over RISE decision-making. In Makassar, no significant predictors of satisfaction were identified. In Suva, significant predictors of satisfaction included gender, religion, and marital status, with women wanting more influence and religious minorities and unmarried participants wanting less influence over decisions. Qualitative data showed that most participants felt satisfied by RISE’s inclusive and participatory design, although some residents reported distrust with RISE and feeling excluded from activities by community representatives.
While RISE participatory design activities achieved good reach and satisfaction overall, we identified specific gender and social inequities in participation and influence over decision-making. We recommend that WASH interventions reflect on the quality of their engagement with communities and local organizations in order to identify and appropriately include groups of interest.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
The RISE trial is registered with the Australian and New Zealand Clinical Trials Registry (ACTRN12618000633280 https://www.anzctr.org.au/).
Funding Statement
The data collected for this project was made possible by the generous support of the Australian Department of Foreign Affairs and Trade (DFAT) through the Water for Women Fund [WRA 1023 to BB and SS]. The RISE program is funded by the Wellcome Trust [grant 205222/Z/16/Z], the New Zealand Ministry of Foreign Affairs and Trade, the Australian Department of Foreign Affairs and Trade, the Government of Fiji, the Asian Development Bank and Monash University, and involves partnerships and in-kind contributions from the City of Makassar, the Cooperative Research Centre for Water Sensitive Cities (now Water Sensitive Cities Australia), Fiji National University, Hasanuddin University, Stanford University, Emory University, Melbourne University, Southeast Water, Melbourne Water, Live and Learn Environmental Education, UN-Habitat, UNU-IIGH, WaterAid International and Oxfam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval for the RISE trial and the research described in this article were obtained from the Monash University Human Research Ethics Committee (Melbourne, Australia project IDs 35903 and 22726) effective as of November 2, 2022, Universitas Hasanuddin (Makassar, Indonesia protocols UH18020110 and UH20050235), and Fiji National University (Suva, Fiji protocol 137.19). Additional approval for this study was obtained from the University of the South Pacific. The parent study included Emory University researchers in IRB applications prior to data collection.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
If the manuscript is accepted by [journal], the authors will make data available in line with the [journal's] Data Policy.
